Collectively, these results suggested that hepatic Zbtb18 expression inhibited NLRP3 inflammasome’s activation in macrophages via an FXR-mediated CLTC protein expression, which helped mitigate NAFLD in mice. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.